Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 1
1989 1
1990 1
1991 2
1992 1
1993 1
1994 1
1995 2
1996 5
1997 1
1998 2
1999 2
2000 5
2001 2
2003 2
2004 2
2005 1
2006 1
2007 3
2008 3
2009 2
2019 1
2020 1
2021 4
2023 1
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.
Paz-Ares L, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Özgüroğlu M, Ji JH, Voitko O, Poltoratskiy A, Ponce S, Verderame F, Havel L, Bondarenko I, Kazarnowicz A, Losonczy G, Conev NV, Armstrong J, Byrne N, Shire N, Jiang H, Goldman JW; CASPIAN investigators. Paz-Ares L, et al. Lancet. 2019 Nov 23;394(10212):1929-1939. doi: 10.1016/S0140-6736(19)32222-6. Epub 2019 Oct 4. Lancet. 2019. PMID: 31590988 Clinical Trial.
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.
Goldman JW, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Özgüroğlu M, Ji JH, Garassino MC, Voitko O, Poltoratskiy A, Ponce S, Verderame F, Havel L, Bondarenko I, Każarnowicz A, Losonczy G, Conev NV, Armstrong J, Byrne N, Thiyagarajah P, Jiang H, Paz-Ares L; CASPIAN investigators. Goldman JW, et al. Lancet Oncol. 2021 Jan;22(1):51-65. doi: 10.1016/S1470-2045(20)30539-8. Epub 2020 Dec 4. Lancet Oncol. 2021. PMID: 33285097 Clinical Trial.
[Bouveret's syndrome].
Bruni R, Bartolucci R, Biancari F, Cataldi C. Bruni R, et al. Among authors: bartolucci r. G Chir. 1993 Oct;14(8):439-41. G Chir. 1993. PMID: 8136238 Review. Italian.
[Fibrous tumors localized in the pleura].
Biancari F, D'Andrea V, Santoni F, Bartolucci R, De Antoni E. Biancari F, et al. Among authors: bartolucci r. G Chir. 1996 Aug-Sep;17(8-9):437-43. G Chir. 1996. PMID: 9004842 Review. Italian.
Screening for epidermal growth factor receptor mutations in lung cancer.
Rosell R, Moran T, Queralt C, Porta R, Cardenal F, Camps C, Majem M, Lopez-Vivanco G, Isla D, Provencio M, Insa A, Massuti B, Gonzalez-Larriba JL, Paz-Ares L, Bover I, Garcia-Campelo R, Moreno MA, Catot S, Rolfo C, Reguart N, Palmero R, Sánchez JM, Bastus R, Mayo C, Bertran-Alamillo J, Molina MA, Sanchez JJ, Taron M; Spanish Lung Cancer Group. Rosell R, et al. N Engl J Med. 2009 Sep 3;361(10):958-67. doi: 10.1056/NEJMoa0904554. Epub 2009 Aug 19. N Engl J Med. 2009. PMID: 19692684 Free article.
Adjuvant arteriovenous fistula in infrapopliteal bypasses.
D'Andrea V, Lepäntalo M, Kantonen I, Biancari F, Di Matteo FM, Bartolucci R, Spyrou M, De Antoni E. D'Andrea V, et al. Among authors: bartolucci r. G Chir. 1998 Mar;19(3):117-9. G Chir. 1998. PMID: 9577087
[Spontaneous nephro-cutaneous fistula].
Bruni R, Bartolucci R, Biancari F, Santoro M. Bruni R, et al. Among authors: bartolucci r. Minerva Chir. 1995 Apr;50(4):413-5. Minerva Chir. 1995. PMID: 7675292 Review. Italian.
49 results